EDUCATION
Biotech Investing Guides
Free, in-depth guides covering the catalysts, signals, and risks that move biotech stocks. From FDA approval deadlines to dark pool flows — everything you need to make informed decisions.
📋
What is a PDUFA Date?
The FDA’s drug approval deadline and why it’s the most important catalyst in biotech.
Read guide →
📝
FDA Complete Response Letters
What happens when the FDA says no — CRL outcomes and what they mean for investors.
Read guide →
🔬
Phase 2 vs Phase 3 Clinical Trials
Key differences between Phase 2 and Phase 3 and why Phase 3 matters most.
Read guide →
💉
Clinical Trial Phases (I–IV)
The complete drug development pipeline from preclinical through post-marketing.
Read guide →
🏛️
FDA Advisory Committee Meetings
How AdCom votes move stocks and predict FDA decisions.
Read guide →
📉
Short Interest in Biotech
What high short interest means and when it signals a squeeze.
Read guide →
🏦
Dark Pool Trading in Biotech
How hidden institutional orders reveal smart money positioning.
Read guide →
💧
Biotech Dilution Risk
The #1 financial risk for pre-revenue biotechs and how to spot it.
Read guide →
📊
13F Institutional Fund Flows
Track smart money — what hedge fund 13F filings reveal about biotech.
Read guide →
🏛️
Congress Trading in Biotech
What STOCK Act filings reveal about congressional pharma trades.
Read guide →
🎯
Signal Convergence
When multiple catalysts align — the strongest signal in biotech.
Read guide →
📑
The Patent Cliff
Drug patent expiry and its impact on pharma revenue.
Read guide →
👤
Insider Trading Signals
Reading SEC Form 4 filings — what insider buys really mean.
Read guide →